Placement Pending
Odyssey Therapeutics placement
US$25m raised
Announced 7 May 2026 · NASDAQ: ODTX · US$18.00 cash per share
Advisers
Odyssey Therapeutics
Issuer
Not disclosed
Lead managers
- Legal adviser
- Issuer
- Odyssey Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Adial Pharmaceuticals placement Jun 2026 · US$32m · Biotech
- Ensysce Biosciences placement Aug 2026 · US$43m · Biotech
- Skye Bioscience placement Aug 2026 · US$68m · Biotech
- Parabilis Medicines placement Jun 2026 · US$75m · Biotech
- ADARx Pharmaceuticals placement Sep 2026 · US$89m · Biotech
Sources
- 7 May 2026 Odyssey Therapeutics Announces $279 Million Upsized IPO, Concurrent $25 Million Private Placement cooley.com
- 8 May 2026 Final IPO prospectus (424B4), Odyssey Therapeutics, Inc. sec.gov

